Early research (Phase 1)Ended earlyNCT02936102
What this trial is testing
FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.
Who this might be right for
Advanced Solid TumorsTriple Negative Breast CancerChordoma and Alveolar Soft Part Sarcoma
Novartis Pharmaceuticals 154